Current CD4 Cell Count and the Short‐Term Risk of AIDS and Death before the Availability of Effective Antiretroviral Therapy in HIV‐Infected Children and Adults

Authors:
  • H(HIV Paediatric Prognostic Markers Collaborative Study (HPPMCS)
    HIV Paediatric Prognostic Markers Collaborative Study (HPPMCS)
  • CCConcerted Action on Sero‐Conversion to AIDS and Death in Europe (CASCADE) Collaboration
    Concerted Action on Sero‐Conversion to AIDS and Death in Europe (CASCADE) Collaboration

Abstract
Background. Currently, there are no comparable estimates of the short-term risk of disease progression in the absence of effective antiretroviral therapy for human immunodeficiency virus (HIV)—infected adults and children.

This publication has 18 references indexed in Scilit: